Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 306 participants.
Also called NCT07365475
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 306 participants
- Sponsor
- Registry
-
NCT07365475
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07365475. Randomized; single masking; primary purpose treatment. Start 2026-01-30 (anticipated); primary completion 2028-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
- Acronym
- AMASS2
- Condition
- Acute Ischemic Stroke From Large Vessel Occlusion
- Intervention (Drug)
- 20% human serum albumin
- Lead sponsor
- Tianjin Huanhu Hospital
Record details
- Record id
cardio:ct-nct07365475- Content hash
c16300930d8cb5517ac6ba0c433553d2f55f775e13a04dbae5710885f60d15ae